CONFIRMED SPEAKERS
Bachar AfandiMD
Al Ain, United Arab Emirates
Read Biography
Bachar Afandi, MD
COMING SOON
Ramzi AjjanMD, FRCP, MMed.Sci, PhD
Leeds, United Kingdom
Read Biography
Ramzi Ajjan, MD, FRCP, MMed.Sci, PhD
COMING SOON
Naji AlamuddinMB BCh BAO
Manama, Bahrain
Read Biography
Naji Alamuddin, MB BCh BAO
Dr. Naji Alamuddin received his medical degree from the Royal College of Surgeons in Ireland, and Masters in Translational Research from the University of Pennsylvania. He completed an internal medicine residency at Pennsylvania Hospital, and fellowship in diabetes, endocrinology, and metabolism at the Hospital of the University of Pennsylvania. He then joined the faculty of the Perelman School of Medicine- at the University of Pennsylvania as an assistant professor in medicine. He moved to Bahrain in August 2018 as a senior lecturer in medicine at the Royal College of Surgeons in Ireland-Medical University of Bahrain and as a consultant endocrinologist at King Hamad University Hospital. He is an adjunct assistant professor in medicine at the University of Pennsylvania. He is board certified in internal medicine, endocrinology, diabetes, and metabolism, and is a Diplomate of the American Board of Obesity Medicine. He is currently enrolled in a Master of Education for Health Professionals at Johns Hopkins University. Dr. Alamuddin’s research focuses on the treatment of obesity, involving behavioral, pharmacological, and surgical approaches. He is primarily interested in understanding metabolic changes associated with weight loss and bariatric surgery. He has worked on complex mechanistic human studies from conception to implementation, and has extensive research experience in the fields of lipid metabolism and obesity. Dr. Alamuddin was previously awarded an NIH K12 Mentored Clinical Scientist Development Program award.
Salem BeshyahMBBCh, PhD, FRCP, FACP
Abu Dhabi, United Arab Emirates
Read Biography
Salem Beshyah, MBBCh, PhD, FRCP, FACP
Dr. Beshyah qualified from the Medical School of Tripoli in 1981. He started his clinical training in Tripoli till 1985 when he moved to the UK. He obtained his MRCP (UK) and MRCPI during his introductory year in Scotland under the auspices of the Royal College of Physicians and Surgeons of Glasgow. He then trained as a clinical registrar in Leicester and Bedford (1987-1989). He complete a four-year clinical research fellowship in working on the clinical and metabolic consequences of hypopituitarism and growth hormone deficiency which was the subject of his PhD thesis. After further clinical training, he was appointed consultant physician in diabetes and endocrinology in Harlow, Essex UK for 10 years. He is very keen on education and was the RCP Tutor for the last 3 years in Harlow. In 2006, Dr. Beshyah, moved to his current post in 2006. He is very keen on education and was the RCP Tutor for the last 3 years in Harlow and coordinated a busy CME program in Diabetes and Endocrinology at the SKMC, Center for Diabetes and endocrinology since his arrival. He is as associate editor of Ibnosina Journal of medicine and biomedical journal and has 39 entries in Medline in addition to numerous peer-reviewed articles and book chapters. He is the honorary treasurer of the Libyan association for diabetes and endocrinology and is a Board Member for the Gulf Chapter of the American Association of Clinical Endocrinologists. His Interests include: practical management of diabetes, endocrine disorders during pregnancy, diabetic foot and cardiovascular disorders in diabetes.
Bassam Bin AbbasMD
Riyadh, Kingdom of Saudi Arabia
Read Biography
Bassam Bin Abbas, MD
Dr. Bassam Saleh Bin-Abbas is a Consultant in the Section of Endocrinology and Diabetes, Department of Pediatrics at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia. He is also a Professor of Pediatrics and Endocrinology at the Al-Faisal University. In the USA, he obtained certification at the American Board of Pediatrics after completing his residency program at Yale University in 1997 and American Board of Pediatric Endocrinology after his fellowship training at UCSF/Stanford University in 1999.
Noor Al BusaidiMD
Muscat, Oman
Read Biography
Noor Al Busaidi, MD
Dr. Noor Al Busaidi completed her Internal Medicine Residency Program as well as her Endocrinology Fellowship at the George Washington Medical Center and Veterans Affairs Medical Center in Washington DC, United States of America. She graduated from Sultan Qaboos University Medical School in Oman.
Dr. Al Busaidi is the Director of National Diabetes & Endocrine Center and a Senior Consultant Physician in the Sultanate of Oman. Additionally, Dr. Al Busaidi is an active member of the National NCD Committee at the MOH and team leader for National Diabetes and National Obesity Training Initiatives in Oman. Previously, Dr. Al Busaidi held multiple key positions including: Chairperson of the National Diabetes Management Service Development Committee at the Ministry of Health, Director and subsequently the Chairperson of the Internal Medicine Residency Program. Furthermore, Dr. Al Busaidi is the founder and President of the Oman Diabetes Association and a member of the American Association for Clinical Endocrinology and American Diabetes Association.
Dr. Al Busaidi has been a keynote speaker and a lecturer at many national and international conferences. Her areas of interests include, but not limited to, Diabetes, Metabolic Syndrome, and Obesity with a special focus on patients advocacy and empowerment, health professional training, and sustainable healthy lifestyle that fights diabetes and Obesity pandemic.
Dr. Al Busaidi is the Director of National Diabetes & Endocrine Center and a Senior Consultant Physician in the Sultanate of Oman. Additionally, Dr. Al Busaidi is an active member of the National NCD Committee at the MOH and team leader for National Diabetes and National Obesity Training Initiatives in Oman. Previously, Dr. Al Busaidi held multiple key positions including: Chairperson of the National Diabetes Management Service Development Committee at the Ministry of Health, Director and subsequently the Chairperson of the Internal Medicine Residency Program. Furthermore, Dr. Al Busaidi is the founder and President of the Oman Diabetes Association and a member of the American Association for Clinical Endocrinology and American Diabetes Association.
Dr. Al Busaidi has been a keynote speaker and a lecturer at many national and international conferences. Her areas of interests include, but not limited to, Diabetes, Metabolic Syndrome, and Obesity with a special focus on patients advocacy and empowerment, health professional training, and sustainable healthy lifestyle that fights diabetes and Obesity pandemic.
Khaled Al DahmaniMD, MBBS, FRCPC
Al Ain, United Arab Emirates
Read Biography
Khaled Al Dahmani, MD, MBBS, FRCPC
Khaled Aldahmani is a Consultant Endocrinologist at Tawam Hospital in Al Ain, United Arab Emirates. He is also a Visiting Endocrinologist at New Medical Center (NMC) and Adjunct Faculty of the Department of Medicine at United Arab Emirates University. Dr. Aldahmani obtained his MBBS at the UAE University in 2006 and completed his residency in Internal Medicine at the University of British Columbia in 2011 and fellowship in Endocrinology at the Dalhousie University, Canada in 2013. Then he completed 1 year training in Pituitary Disorders and Thyroid cancer at Dalhousie University in 2014. He received board certification in Endocrinology, Diabetes and Metabolism (2013) and Internal Medicine (2011) from the American Board of Internal Medicine, as well as a certificate in Endocrinology and Metabolism (2013) and Internal Medicine (2011) from the Fellow of Royal College of Physicians and Surgeons Canada. He is a founding member and the chairman of AlAin Internal Medicine Research conference since 2015.
Dr. Aldahmani has special interest in pituitary disorders and has published the largest population based epidemiological study on sellar masses in North America. He is also a co-author of several other publications.
Dr. Aldahmani has special interest in pituitary disorders and has published the largest population based epidemiological study on sellar masses in North America. He is also a co-author of several other publications.
Asma DeebDCH, MRCP, MD, CCST, FRCPCH
Abu Dhabi, United Arab Emirates
Read Biography
Asma Deeb, DCH, MRCP, MD, CCST, FRCPCH
Prof Asma Deeb is the chief of Paediatric Endocrinology at Mafraq hospital, Abu Dhabi and a clinical professor at the Gulf University, UAE.
She is the President of the Arab Society of Paediatric Endocrinology (ASPED) and Diabetes and the ASPED representative of the Global Pediatric Endocrinology Association.
Prof Deeb is the Chair of communication of the European Society of Paediatric Endocrinology (ESPE) and a member in the advisory board of the International Society of the Pediatric and Adolescent Diabetes Society (ISPAD).
She has various publications in peer-review journals and has special interest in genetics of endocrine disorders and use of technology in Diabetes treatment.
She is the President of the Arab Society of Paediatric Endocrinology (ASPED) and Diabetes and the ASPED representative of the Global Pediatric Endocrinology Association.
Prof Deeb is the Chair of communication of the European Society of Paediatric Endocrinology (ESPE) and a member in the advisory board of the International Society of the Pediatric and Adolescent Diabetes Society (ISPAD).
She has various publications in peer-review journals and has special interest in genetics of endocrine disorders and use of technology in Diabetes treatment.
John DixonMBBS, PhD, FRACGP, FRCP Edin
Melbourne, Australia
Read Biography
John Dixon, MBBS, PhD, FRACGP, FRCP Edin
Professor John Dixon MBBS, PhD, FRACGP, FRCP Edin, is a Professorial Research Fellow in Clinical Obesity Research at the Baker Heart and Diabetes Institute in Melbourne, Australia. In addition he is an Adjunct Professor at both the School of Primary Health Care, Monash University, and the Iverson Health Innovation Research Institute, Swinburne University in Melbourne. An experienced clinician, Professor Dixon has concentrated on obesity research since 1998. Known internationally for his clinical research into obesity and its comorbid conditions as well as weight loss treatments and their effects on health, he is rated in the top researchers worldwide in the fields of obesity; weight loss; morbid obesity; bariatrics; and bariatric surgery (expertscape.com). He has well over 200 original research and review publications in a wide range of peer reviewed journals in addition to numerous invited commentaries, guideline and position statements and book chapters. He was a co author on the consensus American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient in 2009 and the update in 2013.
John is focused on seeing findings translated into clinical practice and on patient advocacy for the obese. He is involved in a wide range of organizations in Australia and internationally, is a member of the scientific advisory council of Obesity Australia and was president of ANZOS 2007-2009. He is Co Editor in Chief of Current Obesity Reports, an Associate Editor of Clinical Obesity, Obesity Surgery and SOARD, and is on the editorial boards of Nutrition and Diabetes, Bariatric News, Diabesity in Practice and Obesity Science and Practise.
John is focused on seeing findings translated into clinical practice and on patient advocacy for the obese. He is involved in a wide range of organizations in Australia and internationally, is a member of the scientific advisory council of Obesity Australia and was president of ANZOS 2007-2009. He is Co Editor in Chief of Current Obesity Reports, an Associate Editor of Clinical Obesity, Obesity Surgery and SOARD, and is on the editorial boards of Nutrition and Diabetes, Bariatric News, Diabesity in Practice and Obesity Science and Practise.
Tarik ElhaddMBBS, MRCP, MD, FRCP, FACE
Doha, Qatar
Read Biography
Tarik Elhadd, MBBS, MRCP, MD, FRCP, FACE
COMING SOON
Thamer AlessaMD, FACE, CCD
Kuwait City, Kuwait
Read Biography
Thamer Alessa, MD, FACE, CCD
Consultant physician and Head of the Division of Endocrinology, Diabetes & Metabolism at Jaber Al-Ahmad Hospital and a Clinical Staff at Dasman Diabetes Institute in Kuwait. Received the bachelor’s degree of Medicine and Surgery form the University of Kuwait, Faculty of Medicine. Certified by the American Board of Internal Medicine after completing residency in Internal Medicine and fellowship in Endocrinology, Diabetes and Metabolism at the University of Miami, Jackson Memorial Hospital and Miami VA Hospital. Fellow of the American College of Endocrinology. Vice President of the Kuwait Osteoporosis Society and a past Board Member of the Kuwait Endocrine Society. Chair of the Examination Committee of the Kuwaiti Board of Endocrine and Diabetes Fellowship Program and a member of the Examination Committee of the Kuwaiti Board of Internal Medicine Residency Program.
Diego FeroneMD, PhD
Genoa, Italy
Read Biography
Diego Ferone, MD, PhD
Dr. Ferone is Professor of Endocrinology at the Department of Internal Medicine & Medical Specialties, at the University of Genova, senior member and secretary of the Italian Endocrine Society (where he also served as Treasurer), past-secretary of the Italian Society of Andrology and Sexual Medicine, member of the Advisory Board of the European Neuroendocrine Tumor Society, of the ExCo of the European Neuroendocrine Association until October 2016, and of several Editorial Boards, Associate Editor for the Journal of Endocrinological Investigation and past editor for Clinical Endocrinology.
Dr. Ferone, after the degree in Medicine and the postgraduate degree in Endocrinology and Metabolic Diseases at the “Federico II” University of Naples, received the PhD degree in Neuroendocrinology in Rotterdam at the Erasmus University, where he spent more than 4 years in the laboratory of Steven Lamberts and Leo Hofland. He has been awarded by the Italian Society of Endocrinology as best young investigator in 1999, and received the career award in 2011, he also received an Award as best researcher in the field of Neuroendocrine Tumor and MEN in 2010. Dr. Ferone has been constantly involved in studies on the physiopathology and treatment of pituitary and neuroendocrine tumors, physiopathology of somatostatin and dopamine receptors in the immune and neuroendocrine systems, medical therapy of acromegaly, Cushing disease, and hypopituitarism, and is author of more than 200 articles, he presented more than 500 lectures in international and national meetings, and is author of 20 chapters of book (total impact factor 487; h-index 44). He has been among the organizers of the XXXI Congress of Italian Endocrine Society (Genova 2005), of the First Italian Endocrine Oncology Workshop (Udine 2009) and of the First National Congress of Endocrine Oncology: from bench to bedside (Rome 2011), of the Master Up-to Date in Neuro-Onco-Endocrinology (2010 Genova); dr. Ferone has been member of the POC of the 2010 ENEA Meeting (Liege, Belgium), of the 12th International Workshop on Multiple Endocrine Neoplasia (Gubbio, Italy 2010), of the 2019 ECE (Lyon, France), as well as President of the POC of the 2016 ENEA Meeting (Milano, Italy).
Dr. Ferone, after the degree in Medicine and the postgraduate degree in Endocrinology and Metabolic Diseases at the “Federico II” University of Naples, received the PhD degree in Neuroendocrinology in Rotterdam at the Erasmus University, where he spent more than 4 years in the laboratory of Steven Lamberts and Leo Hofland. He has been awarded by the Italian Society of Endocrinology as best young investigator in 1999, and received the career award in 2011, he also received an Award as best researcher in the field of Neuroendocrine Tumor and MEN in 2010. Dr. Ferone has been constantly involved in studies on the physiopathology and treatment of pituitary and neuroendocrine tumors, physiopathology of somatostatin and dopamine receptors in the immune and neuroendocrine systems, medical therapy of acromegaly, Cushing disease, and hypopituitarism, and is author of more than 200 articles, he presented more than 500 lectures in international and national meetings, and is author of 20 chapters of book (total impact factor 487; h-index 44). He has been among the organizers of the XXXI Congress of Italian Endocrine Society (Genova 2005), of the First Italian Endocrine Oncology Workshop (Udine 2009) and of the First National Congress of Endocrine Oncology: from bench to bedside (Rome 2011), of the Master Up-to Date in Neuro-Onco-Endocrinology (2010 Genova); dr. Ferone has been member of the POC of the 2010 ENEA Meeting (Liege, Belgium), of the 12th International Workshop on Multiple Endocrine Neoplasia (Gubbio, Italy 2010), of the 2019 ECE (Lyon, France), as well as President of the POC of the 2016 ENEA Meeting (Milano, Italy).
Hossein GharibMD, MACP, MACE
Rochester, Minnesota, United States of America
Read Biography
Hossein Gharib, MD, MACP, MACE
Hossein Gharib, a graduate of the University of Michigan Medical School, completed Internal Medicine residency and fellowship in Endocrinology and Metabolism at the Mayo Clinic, where he is currently Professor of Medicine.
Dr. Gharib is an international authority on thyroid disorders, having published more than 200 peer-reviewed papers and lectured at more than 350 national & international endocrine events. He has received many honors & awards, including the prestigious Paul Starr Award of the American Thyroid Association and the Distinguished Physician Award of the Endocrine Society. He is a Master of both the American College of Physicians and the American College of Endocrinology, and received an honorary doctorate degree from “Carol Davila” University of Medicine & Pharmacy in Romania in 2015. He is a Past President of the American Association of Clinical Endocrinologists, the American College of Endocrinology, and the American Thyroid Association. His citation index is >8700 and H-index 49.
Dr. Gharib is an international authority on thyroid disorders, having published more than 200 peer-reviewed papers and lectured at more than 350 national & international endocrine events. He has received many honors & awards, including the prestigious Paul Starr Award of the American Thyroid Association and the Distinguished Physician Award of the Endocrine Society. He is a Master of both the American College of Physicians and the American College of Endocrinology, and received an honorary doctorate degree from “Carol Davila” University of Medicine & Pharmacy in Romania in 2015. He is a Past President of the American Association of Clinical Endocrinologists, the American College of Endocrinology, and the American Thyroid Association. His citation index is >8700 and H-index 49.
Ahmed HassounMD, FACE, FACP
Dubai, United Arab Emirates
Read Biography
Ahmed Hassoun, MD, FACE, FACP
Ahmed Hassoun completed his residency training in Internal Medicine at Brown University, Rhode Island, USA. After 3 years of extensive clinical and research fellowship in Endocrinology, Diabetes & Metabolism at the Mayo Clinic in Rochester, Minnesota, he joined the Endocrinology staff at Mayo Clinic. He is American board certified in both Internal Medicine & Endocrinology, Diabetes, and Metabolism. Dr. Hassoun is a fellow of the American College of Physicians and the American College of Endocrinology. In addition, he is an active member of: American Diabetes Association(ADA), the Endocrine Society (ES), and the American Association of Clinical Endocrinologists (AACE). His previous appointments included: Chief of Endocrinology, Emirates Diabetes Society Board member, Clinical Assistant Professor at Wayne State University in Michigan and the Faculty of Medicine at the UAE University. He has been actively participating in: developing and updating the UAE Diabetes guidelines, educating & training doctors & other healthcare providers, as well as conducting research in the field of diabetes & endocrinology. Dr. Hassoun is a founding member and active coordinator of the monthly UAE Endocrinology meetings, which was established in the year 2000, to encourage up-to-date education and dialogue amongst endocrinologists.
Abdullah Al HerbishMBBS, FRCP, FAAP
Riyadh, Kingdom of Saudi Arabia
Read Biography
Abdullah Al Herbish, MBBS, FRCP, FAAP
Born in Saudi Arabia, Prof. Abdullah Al Herbish graduated in King Saud University Medical School in 1981. He obtained post-graduate training and degrees in Pediatrics and Pediatric Endocrinology in Alberta Child Hospital, Calgary, Canada and Hospital for Sick Children in Toronto, Canada 1984-1989. He is of FRCPC and FAAP holder in both Pediatrics and Pediatric Endocrinology. He worked in King Khalid University Hospital, King Saud University, Riyadh till 2009. He is currently, holding a position as Vice President of Physicians’ Affairs in Dr. Sulaiman Al Habib Medical Group (HMG) and Professor of Pediatrics and Pediatric Endocrinology. He is an author or co-author of more than 90 published papers, chapters and books. He has been an invited speaker and chairman in many symposia and conferences.
Wiam HusseinMD
Manama, Bahrain
Read Biography
Wiam Hussein, MD
COMING SOON
Nasser AljuhaniMD, FRCP (UK), CPHQ, PHMD
Jeddah, Kingdom of Saudi Arabia
Read Biography
Nasser Aljuhani, MD, FRCP (UK), CPHQ, PHMD
Nasser Rajallah Al Juhani is consultant internist & endocrinologist at East Jeddah hospital (300-bed capacity) & King Abdulaziz hospital (450-bed capacity) MOH,JCI-accredited hospitals, Jeddah, KSA since 2004. Aljuhani was graduated 1994 from King Abdulaziz university, Jeddah, KSA. He completed his residency training program in internal medicine at King Abdualziz hospital & oncology center, Jeddah at 2000. He completed his two years fellowship program in endocrinology & metabolism at King Faisal specialist hospital & research center, Riyadh, KSA, 2004.He awarded Arab Board (ABIM), Saudi Board (SBIM) & Membership of Royal College of Physician of Internal Medicine (MRCP,UK) certifications of Internal Medicine at 2001.He obtained Fellowship of Royal College of Physician of Internal Medicine – Endocrine,(FRCP),UK, Edinburg, U.K, 2009 & Membership of Royal College of Physician of Endocrinology & Diabetes (MRCP,UK) 2017.
He had more than 16 years’ experience of managing various types of endocrine disorders & diabetes .He is the chief of executive committee -Jeddah of Saudi society of endocrinology & metabolism(SSEM) since 2011 & secretary of AACE gulf chapter. He is actively involved in many local endocrine scientific activities. He is a member of many hospital wide committees & local, regional, international scientific associations. He has 15 publications in peer reviewed journals.
He is a Certified Professional in Health Care Quality (CPHQ) & awarded Professional Post Graduate Diploma in Healthcare & Hospital Management at from American university .He was the chief of Internal Medicine at East Jeddah hospital ,2017 -2018 & the Supervisor of Endocrine & Diabetes health care services, Jeddah region ,MOH, KSA 2017. He was appointed as Director of ALThagar General Hospital, Jeddah, KSA, 2012 - 2016 & Supervisor General of New Jeddah East Hospital project, Jeddah, KSA.2012- 2013 .He was appointed as Assistant supervisor general for medical affair (Medical director) & chief of internal medicine at king Abdul-Aziz Hospital & Oncology center ( KAAH&OC), Jeddah, KSA. He was deputy chairman of medical education & Director, Saudi board internal medicine residency Training program at KAAH&OC, Jeddah 2004 – 2006.He have vast experience in health care quality accrediting bodies standards: Central Board Accreditation of Health Care Institutions (CBAHI) & Joint Commission international (JCI).
He had more than 16 years’ experience of managing various types of endocrine disorders & diabetes .He is the chief of executive committee -Jeddah of Saudi society of endocrinology & metabolism(SSEM) since 2011 & secretary of AACE gulf chapter. He is actively involved in many local endocrine scientific activities. He is a member of many hospital wide committees & local, regional, international scientific associations. He has 15 publications in peer reviewed journals.
He is a Certified Professional in Health Care Quality (CPHQ) & awarded Professional Post Graduate Diploma in Healthcare & Hospital Management at from American university .He was the chief of Internal Medicine at East Jeddah hospital ,2017 -2018 & the Supervisor of Endocrine & Diabetes health care services, Jeddah region ,MOH, KSA 2017. He was appointed as Director of ALThagar General Hospital, Jeddah, KSA, 2012 - 2016 & Supervisor General of New Jeddah East Hospital project, Jeddah, KSA.2012- 2013 .He was appointed as Assistant supervisor general for medical affair (Medical director) & chief of internal medicine at king Abdul-Aziz Hospital & Oncology center ( KAAH&OC), Jeddah, KSA. He was deputy chairman of medical education & Director, Saudi board internal medicine residency Training program at KAAH&OC, Jeddah 2004 – 2006.He have vast experience in health care quality accrediting bodies standards: Central Board Accreditation of Health Care Institutions (CBAHI) & Joint Commission international (JCI).
Fahad Al JuraibahMD
Riyadh, Kingdom of Saudi Arabia
Read Biography
Fahad Al Juraibah, MD
Dr. Fahad aljuraibah is a pediatric endocrine consultant and deputy program director of pediatric residency training program at King Abdullah specialized Children Hospital- Riyadh, Suadi Arabia. Also, Dr. Aljuraibah is an assistant professor of pediatrics at King Saud Bin Abdulaziz University for Health Science- Riyadh, Suadi Arabia. He finished his pediatric endocrine training in Saudi Arabia, and then he later obtained a clinical fellowship in pediatric endocrinology focusing on complex bone disorders and disorders of sexual differentiation from the royal hospital for Children, Glasgow, United Kingdom. Dr. AL Juraibah has a great interest in pediatric complex bone disorders and has publications in this field.
Juma Al KaabiMD, FACE
Al Ain, United Arab Emirates
Read Biography
Juma Al Kaabi, MD, FACE
Dr. Al Kaabi obtained the basic medical science degree from the University of St. Andrews Scotland in 1990 and the Medical Degree from University of Manchester- England in 1993. Subsequently trained in Internal Medicine in the United Kingdom followed by Clinical Fellowship in Endocrinology and Metabolism at the University of Alberta, Edmonton, Canada where he spent two years and a half as clinical fellow at the department of Endocrinology and Metabolism and was attached to the islet cell transplant unit. In his current clinical position, he providies comprehensive ambulatory setting and consultative service in General Internal Medicine, Endocrinology, Diabetes and Metabolism. Since his return home, Dr Al Kaabi has made significant contributions into the clinical healthcare system of the UAE through his membership of the Ministry of Health National Diabetes Committee. In the community, he made the speciality of diabetes reachable and understandable by the general population to direct involvement with national guidelines preparations and awareness campaigns. He has been active in contributing to the CME, public health awareness in the community. In addition, he has been successful in organising the Annual Diabetes Workshops in the Faculty of Medicine UAE University and has been a member of the scientific committee for many local conferences, workshops and scientific meetings. . He has been elected recently as member of the board of directors of the Gulf Chapter of the American Association of Clinical Endocrinologists.
David KendlerMD
Vancouver, Canada
Read Biography
David Kendler, MD
Dr. Kendler graduated from the MD program at the University of Toronto in 1977. After completing a rotating internship in Toronto, he practiced for several years in Canada, Botswana, and New Zealand. He returned to Internal Medicine training in 1983 in Christchurch, New Zealand and in 1984 joined the Internal Medicine program in Halifax, Canada. In 1985 he moved to Vancouver to complete Internal Medicine and Endocrinology training at the University of British Columbia. After a 2-year thyroid immunology Fellowship in New York, he returned to the University of British Columbia Faculty of Medicine where he is now a Professor of Medicine (Endocrinology). He has led osteoporosis programs at Children and Women’s Hospital, St. Vincent’s Hospital, and St. Paul’s Hospital. He is the director of the Osteoporosis Centre of British Columbia and Prohealth Clinical Research, a major North American centre for clinical trials in the area of osteoporosis. He serves on the Scientific Advisory Council of Osteoporosis Canada and Chairs the Western Osteoporosis Alliance. He is a Past-President of the International Society for Clinical Densitometry. He is a member of the Committee of Scientific Advisors of the International Osteoporosis Foundation and is co-Chair of the Western Osteoporosis Alliance. He has been awarded the John Bilezekian ISCD Global Leadership Award.. He was a founding member and has served on the Board of Directors of the Canadian Menopause Society. He has published over 120 peer-reviewed papers on osteoporosis therapies, osteoporosis risk assessment technologies, and autoimmune thyroid disease.
Aly B KhalilMD, FRCP, FACE
Abu Dhabi United Arab Emirates
Read Biography
Aly B. Khalil, MD, FRCP, FACE
Dr Aly B. Khalil is currently a consultant endocrinologist at the Imperial London Diabetes Centre- Abu Dhabi (ICLDC) and adjunct associate Professor at the United Arab Emirates University Al Ain UAE. He graduated from the University of Marseille- France than emigrated to Canada where he received his training in Internal Medicine at Queen’s University and Endocrinology at the University of Toronto, Canada. He is an American Board Certified in Internal Medicine, Diabetes and Endocrinology, Fellow of the Royall College of Physicians and Surgeons of Canada and Fellow of the American Association of Clinical Endocrinologists.
With a special interest in the management of thyroid disorders, Dr Aly Khalil has chalked up wide ranging clinical experience, while authoring multiple publications in both areas and presenting at different regional and international meetings.
With a background firmly rooted in North America, he has held different administrative and clinical positions. He is a former President of the Ontario Diabetes Association of Canada, Founding member of the Lebanese American University and Past President of the American Association for clinical endocrinologists-Gulf Chapter.
With a special interest in the management of thyroid disorders, Dr Aly Khalil has chalked up wide ranging clinical experience, while authoring multiple publications in both areas and presenting at different regional and international meetings.
With a background firmly rooted in North America, he has held different administrative and clinical positions. He is a former President of the Ontario Diabetes Association of Canada, Founding member of the Lebanese American University and Past President of the American Association for clinical endocrinologists-Gulf Chapter.
Rayaz MalikMBChB, PhD, FRCP
Doha, Qatar
Read Biography
Rayaz Malik, MBChB, PhD, FRCP
Rayaz Malik graduated in Medicine from the University of Aberdeen in 1991, obtained his MRCP in 1996, PhD from the University of Manchester in 1997 and was elected to become a fellow of the Royal College of Physicians in 2007. He was appointed as Consultant Physician and Senior Lecturer in 2001 and as Professor of Medicine and Consultant Physician in 2008 in Central Manchester University Teaching Hospitals and the University of Manchester. He was appointed as Professor of Medicine at Weill Cornell Medicine in 2014 and is an honorary Professor of Medicine and Consultant Physician at Central Manchester University Teaching Hospitals and University of Manchester and visiting Professor of Medicine at Manchester Metropolitan University. He was appointed as the Organizational Official for Weill Cornell Medicine in Qatar in November 2016.
His research focuses on the pathogenesis, assessment and treatment of diabetic neuropathy and cardiomyopathy and is funded by the NIH, JDRF, QF, ECTRIMS and MJFF. He was called to provide expert advice to NICE on diabetic gastroparesis and painful diabetic neuropathy in 2014. Over the last 15 years he has pioneered the use of corneal confocal microscopy, a non-invasive ophthalmic instrument, to quantify diabetic and other peripheral neuropathies. More recently he has applied CCM to establish it as a surrogate for neuronal damage in patients with Stroke, Multiple Sclerosis, Parkinson’s disease and Dementia.
He was the President of Neurodiab (the diabetic neuropathy study group of the EASD) from 2009-2012. He is an associate editor for Diabetic Medicine (2006 to present); J of Diabetes and its Complications (2012-present), PLOS One (2016-present), BMC Neurology (2009-present) and Advances in Therapy (2009-present). He is on the Juvenile Diabetes Research Foundation Complications and Clinical Investigation Research Committee (2005-present) and served on the MRC Clinical Translational research panel from 2012-2014.
His research focuses on the pathogenesis, assessment and treatment of diabetic neuropathy and cardiomyopathy and is funded by the NIH, JDRF, QF, ECTRIMS and MJFF. He was called to provide expert advice to NICE on diabetic gastroparesis and painful diabetic neuropathy in 2014. Over the last 15 years he has pioneered the use of corneal confocal microscopy, a non-invasive ophthalmic instrument, to quantify diabetic and other peripheral neuropathies. More recently he has applied CCM to establish it as a surrogate for neuronal damage in patients with Stroke, Multiple Sclerosis, Parkinson’s disease and Dementia.
He was the President of Neurodiab (the diabetic neuropathy study group of the EASD) from 2009-2012. He is an associate editor for Diabetic Medicine (2006 to present); J of Diabetes and its Complications (2012-present), PLOS One (2016-present), BMC Neurology (2009-present) and Advances in Therapy (2009-present). He is on the Juvenile Diabetes Research Foundation Complications and Clinical Investigation Research Committee (2005-present) and served on the MRC Clinical Translational research panel from 2012-2014.
Ali Al MamariMBChB, MD, FRCP
Muscat, Oman
Read Biography
Ali Al Mamari, MBChB, MD, FRCP
COMING SOON
Glenn MatfinMB ChB
Dubai, United Arab Emirates
Read Biography
Glenn Matfin, MB ChB
Professor Glenn Matfin is Professor of Medicine, MBRU College of Medicine, UAE.
He obtained his medical education in the UK (including MSc in Experimental Therapeutics at the University of Oxford) and USA. He trained in Endocrinology and Diabetes in Newcastle (with Sir George Alberti) and London, UK; as well as the US National Institutes of Health (NIH), working with Pima American Indians.
He has been a clinician-educator-researcher specializing in General Medicine, Diabetes and Endocrinology for over 30 years including being Senior Physician and Director of the Inpatient Diabetes Team at the Joslin Diabetes Center, Harvard Medical School, USA; Medical Director and Clinical Professor of Medicine, WHO Collaborating Center for Diabetes, International Diabetes Center and Mayo Clinic, USA; and Consultant Physician and Honorary Professor of Medicine, Acute and General Medicine, Diabetes, and Endocrinology, NHS and Peninsula Schools of Medicine, UK.
He has made important contributions to cardiometabolic research and translation in the UK, USA and internationally. This includes being an ongoing investigator in the landmark study in type 1 diabetes (DCCT/EDIC); Type 1 Diabetes Exchange Clinic Network; and EMPA-REG and LEADER outcome studies.
He has published extensively, including several textbooks (e.g. Endocrine and Metabolic Medical Emergencies, published by the US Endocrine Society, 2018).
He is a keen and effective teacher (e.g. received Harvard Medical School Academy Center for Teaching and Learning, Excellence in Tutoring Award in 2011).
He obtained his medical education in the UK (including MSc in Experimental Therapeutics at the University of Oxford) and USA. He trained in Endocrinology and Diabetes in Newcastle (with Sir George Alberti) and London, UK; as well as the US National Institutes of Health (NIH), working with Pima American Indians.
He has been a clinician-educator-researcher specializing in General Medicine, Diabetes and Endocrinology for over 30 years including being Senior Physician and Director of the Inpatient Diabetes Team at the Joslin Diabetes Center, Harvard Medical School, USA; Medical Director and Clinical Professor of Medicine, WHO Collaborating Center for Diabetes, International Diabetes Center and Mayo Clinic, USA; and Consultant Physician and Honorary Professor of Medicine, Acute and General Medicine, Diabetes, and Endocrinology, NHS and Peninsula Schools of Medicine, UK.
He has made important contributions to cardiometabolic research and translation in the UK, USA and internationally. This includes being an ongoing investigator in the landmark study in type 1 diabetes (DCCT/EDIC); Type 1 Diabetes Exchange Clinic Network; and EMPA-REG and LEADER outcome studies.
He has published extensively, including several textbooks (e.g. Endocrine and Metabolic Medical Emergencies, published by the US Endocrine Society, 2018).
He is a keen and effective teacher (e.g. received Harvard Medical School Academy Center for Teaching and Learning, Excellence in Tutoring Award in 2011).
Huda E. MustafaMSc. FRCP, FACE, ECNU
Abu Dhabi, United Arab Emirates
Read Biography
Huda E. Mustafa, MSc. FRCP, FACE, ECNU
Huda E. Mustafa graduated from King Faisal University in Saudi Arabia before completing her postgraduate training in Internal Medicine and Endocrinology at Imperial College London, UK. She holds a Master’s degree in Diabetes from Warwick University, UK. Since 2014 Dr. Huda has been the Division Head of Endocrinology & Diabetes in Sheikh Khalifa Medical City and the Lead Physician of the thyroid cancer program and Bariatric Medicine. In February 2019, Dr. Huda joint HealthPlus group, a comprehensive center of excellence in diabetes and Endocrinology in the capital of Abu Dhabi.
Huda is a Fellow of the Royal College of Physicians of London and Edinburgh and a Fellow of the American College of Endocrinology. During her appointments in SKMC, has been a key member of multiple committees, including the Institutional Ethics Committee, Pharmaceuticals and Therapeutics, and Chronic Disease Management Committee at the Department of Health of Abu Dhabi.
Throughout her career, medical education has been an ongoing passion. As such, she has participated in, and organized, workshops and training programs for medical students, residents, and peers alike in the field of Research Methodology, Diabetes, Reproductive Endocrinology, and Thyroidology.
Huda is a Fellow of the Royal College of Physicians of London and Edinburgh and a Fellow of the American College of Endocrinology. During her appointments in SKMC, has been a key member of multiple committees, including the Institutional Ethics Committee, Pharmaceuticals and Therapeutics, and Chronic Disease Management Committee at the Department of Health of Abu Dhabi.
Throughout her career, medical education has been an ongoing passion. As such, she has participated in, and organized, workshops and training programs for medical students, residents, and peers alike in the field of Research Methodology, Diabetes, Reproductive Endocrinology, and Thyroidology.
Ebaa Al-OzairiMRCP(UK), CCST, FACN
Kuwait City, Kuwait
Read Biography
Ebaa Al-Ozairi, MRCP(UK), CCST, FACN
Dr Ebaa Al-Ozairi is an assistant professor at Kuwait University and a specialist in diabetes and endocrinology at Mubarak Al-Kabeer hospital. She graduated from Aberdeen University (UK) and has completed her full postgraduate program in Diabetes and Endocrinology from Newcastle University, UK. She was awarded Fulbright fellowship to Joslin Diabetes Center, Harvard medical school.
Her research interest includes diabetes education, obesity, bariatric surgery, and diabetes in young people. Dr Ebaa Al-Ozairi has been accredited by the Royal College of physician as an educator and is an associate practitioner at the UK higher National Academy. Within Kuwait diabetes team, Dr Ebaa considers herself as diabetes friends.
Her research interest includes diabetes education, obesity, bariatric surgery, and diabetes in young people. Dr Ebaa Al-Ozairi has been accredited by the Royal College of physician as an educator and is an associate practitioner at the UK higher National Academy. Within Kuwait diabetes team, Dr Ebaa considers herself as diabetes friends.
Richard QuintonMB, Bchir, MA, MD, FRCP
Newcastle, United Kingdom
Read Biography
Richard Quinton, MB, Bchir, MA, MD, FRCP
COMING SOON
Aisha Mohammed Al SenaniMD, MRCPCH, DCH
Muscat, Oman
Read Biography
Aisha Mohammed Al Senani, MD, MRCPCH, DCH
Senior consultant paediatric endocrinologist and head of paediatric endocrinology in NDEC and Royal hospital. Member of several professional societies, both national and international, such as The Oman paediatric society , Arab Society for Paediatric Endocrinology and Diabetes(ASPED).
Has international links to International Society for Pediatric and Adolescent Diabetes (ISPAD) and the European Society of Pediatric Endocrinology (ESPE). Invited speaker at regional meetings of professional specialty societies, international meetings and symposia. Serves as invited reviewer in national peer-reviewed journals.
Published over 15 papers in international and local periodicals and journals and supervised few resaearhes paediatric residents. Prepared and Supervised and helped in the writing of " Protocols of management of DKA in Type 1 Diabetes, acute endocrine emergencies and common chronic endocrine diseaeas . Participated as a principal investigator of research for both Diabetes and endocrine diseases .involved in many other international clinical and basic research projects .involved in teaching both undergraduate and resident .
Has international links to International Society for Pediatric and Adolescent Diabetes (ISPAD) and the European Society of Pediatric Endocrinology (ESPE). Invited speaker at regional meetings of professional specialty societies, international meetings and symposia. Serves as invited reviewer in national peer-reviewed journals.
Published over 15 papers in international and local periodicals and journals and supervised few resaearhes paediatric residents. Prepared and Supervised and helped in the writing of " Protocols of management of DKA in Type 1 Diabetes, acute endocrine emergencies and common chronic endocrine diseaeas . Participated as a principal investigator of research for both Diabetes and endocrine diseases .involved in many other international clinical and basic research projects .involved in teaching both undergraduate and resident .
Raul SantosMD, MSc, PhD
São Paulo, Brazil
Read Biography
Raul Santos, MD, MSc, PhD
Raul Santos is Director of the Lipid Clinic at the Heart Institute and associate professor of the University of São Paulo (USP) Medical School, Brazil. He is also Scientific Advisor of the Hospital Israelita Albert Einstein in São Paulo. Currently he is the president of the International Atherosclerosis Society (IAS). After completing his training in cardiology Dr. Santos obtained master and PhD degrees in food science at the USP pharmacy school. His research interests include lipid metabolism, severe forms of genetic dyslipidemias, especially FH and HDL deficiency, non-alcoholic fatty liver disease and imaging in atherosclerosis focusing on vascular calcification. He has published more than 280 papers in peer-review journals like the Lancet, The New England Journal of Medicine, Atherosclerosis, ATVB, Circulation, The European Heart Journal, JACC, JACC Cardiovascular Imaging, Journal of Lipid Research, Journal of Clinical Lipidology, Lancet Diabetes & Endocrinology among others. In addition, he is one of the associate editors of Atherosclerosis, the Journal of Clinical Lipidology and the European Journal of Preventive Cardiology. He has received a lifetime membership recognition award from the National Lipid Association, a career achievement award from Oman Society of Lipid and Atherosclerosis (OSLA) and, a Paul Dudley White International Scholar Award from the American Heart Association.
Nasreen AlsayedMD, FACE, FACP
Manama, Bahrain
Read Biography
Nasreen Alsayed, MD, FACP
Nasreen Al-Sayed graduated from Arabian Gulf University, college of Medicine in Bahrain. She is American Board Certified. She completed her Residency training in Internal medicine at Sinai-Grace Hospital, Wayne State University, Detroit, Michigan, USA and Fellowship training in Endocrinology and Diabetes at Cleveland Clinic Foundation, Ohio, USA. Dr. Al-Sayed is also American Board Certified in Clinical Lipidology and a fellow of American College of Physicians and fellow of American College of Endocrinologists. She has worked as assistant professor at Arabian Gulf University and is currently at Gulf Diabetes Specialist Center in Bahrain. Dr. Al-Sayed is a member of the National Lipid Association and other Diabetes and Endocrine Associations and has several research publications. She is a member of Board of Directors of the American Association of Clinical Endocrinologist, Gulf Chapter and a member of expert panel for Middle East Familial Hypercholesterolemia guidelines and FH Gulf registry. She is the National Lead investigator for FH in Bahrain.
Dr. Alsayed participated with expert panel and published first consensus recommendation for management of plasma lipid disorders for Middle East 2016. She has other several publications in the endocrine field.
Dr. Alsayed participated with expert panel and published first consensus recommendation for management of plasma lipid disorders for Middle East 2016. She has other several publications in the endocrine field.
Sandra WeberMD, FACP, FACE
Greenville, United States of America
Read Biography
Sandra Weber, MD, FACP, FACE
Dr. Weber is president of the American Association of Clinical Endocrinologists (AACE). She has been an active member of AACE since her endocrinology fellowship in Miami. She has been active in membership, FACE (Fellow of the American College of Endocrinology), chapter development and leadership. Dr. Weber is honored to represent AACE at this meeting.
Dr. Sandra Weber is Professor of Medicine at the University of South Carolina School of Medicine - Greenville and is Chief of the Division of Endocrinology at the Greenville Health System in Greenville, South Carolina. She received her medical degree from Northwestern University, Honors Program in Medical Education. She completed her internship, residency, chief residency, and fellowship at the University of Miami in Miami, Florida. Dr. Weber specializes in Type 1 diabetes, diabetes prevention and general endocrinology.
Dr. Weber is involved in medical school and residency teaching programs as well as Chair of Continuing Medical Education. She is a strong believer in life long education.
Dr. Sandra Weber is Professor of Medicine at the University of South Carolina School of Medicine - Greenville and is Chief of the Division of Endocrinology at the Greenville Health System in Greenville, South Carolina. She received her medical degree from Northwestern University, Honors Program in Medical Education. She completed her internship, residency, chief residency, and fellowship at the University of Miami in Miami, Florida. Dr. Weber specializes in Type 1 diabetes, diabetes prevention and general endocrinology.
Dr. Weber is involved in medical school and residency teaching programs as well as Chair of Continuing Medical Education. She is a strong believer in life long education.
Ali AlzahraniMD, FACE
Riyadh, Kingdom of Saudi Arabia
Read Biography
Ali Alzahrani, MD, FACE
Dr. Ali S. Alzahrani is a Professor of Medicine and Endocrinology at Al Faisal University in Riyadh. Dr. Ali Zahrani obtained his Medical Degree from King Saud University in 1990. This was followed by Residency in Internal Medicine at KFSH & RC during the period 1991-1995 and Clinical and Research Fellowship at the John Hopkins School of Medicine in Baltimore, USA during the years 1995-1998. He has been a Consultant Endocrinologist at KFSH & RC since 1998. During the period 2010 to 2011, Dr. Alzahrani was a faculty member and visiting Scientist at the Division of Endocrinology and Metabolism in John Hopkins University, School of Medicine, Baltimore, United States of America. Since his return late in 2011, he has become a Scientist and Head of the Molecular Endocrinology Division in the Department of Molecular Oncology, Research Center in addition to his Consultant Endocrinology position. Most recently, he has been appointed as a Deputy Executive Director, Research Center at KFSH & RC, Jeddah.
Dr. Alzahrani is proactive in several editorial boards of famously known medical publications. He was the Editor-in Chief of the Annals of Saudi Medicine and an Editorial Board Member of the British Journal of Diabetes and Vascular Medicine. He is an Editorial Board member of the prestigious official journal of the American Thyroid Association, THYROID. Dr. Alzahrani has more than 70 peer-reviewed articles, more than ninty regional and international presentations and has conducted more than ninety lectures nationally and internationally as an invited speaker. Dr. Al Zahrani’s academic interests are clinical and molecular research in the areas of thyroid cancer and endocrine genetics.
Dr. Alzahrani is proactive in several editorial boards of famously known medical publications. He was the Editor-in Chief of the Annals of Saudi Medicine and an Editorial Board Member of the British Journal of Diabetes and Vascular Medicine. He is an Editorial Board member of the prestigious official journal of the American Thyroid Association, THYROID. Dr. Alzahrani has more than 70 peer-reviewed articles, more than ninty regional and international presentations and has conducted more than ninety lectures nationally and internationally as an invited speaker. Dr. Al Zahrani’s academic interests are clinical and molecular research in the areas of thyroid cancer and endocrine genetics.
